Chemistry Letters Vol.34, No.6 (2005)
801
presence of DBU in THF/DMF at ꢁ75 ꢂC–rt to give the pyrro-
methenone derivative 14 in 74% yield. Compound 14 was
formylated by treating with trimethyl orthoformate in TFA to
give the desired formylated E-anti C/D-ring component 4 in
40% yield.8
O
NH
O2N
Me
OAc
Me
H
CO2tBu
b, c
d
a
O
OH
5
6
7
OAc
8
OAc
O
O
The coupling reaction between the C/D- and A/B-ring
components (4 and 3) was carried out under acidic conditions
to afford the sterically fixed BV diallyl ester derivative 2 in
71% yield.
NH
NBoc
CO2tBu
Ts
Me
Me
CO2tBu
e, f
g, h, i
j, k, l
OAc
Finally, the deprotection of the allyl esters was achieved by
Pd(0)-catalyzed reaction in the presence of sodium p-toluenesul-
finate as nucleophile in THF/MeOH to give the desired BV de-
rivative 1 bearing the E-anti C/D-ring component in 70% yield.9
The chromophore 1 thus prepared was assembled with Agp1
apoprotein and found to form covalent bond showing the absorp-
tion spectrum corresponding to Pfr form.10
9
10
OAc
O
OH
O
Me
NBoc
NBoc
CO2tBu
Ts
Me
CO2tBu
m, n
Ts
NH
NO2
OH
CO2tBu
AllylO2C
The present work was financially supported in part by Grant-
in-Aid for Scientific Research (B) (No. 15350021) from Japan
Society for the Promotion of Science (JSPS). One of the authors
(K. I.) gratefully acknowledges Dr. Tilman Lamparter of Freie
AllylO2C
11
12
Scheme 1. a) In 0.1 M aq HCl, rt, 30 min. b) 1-Nitropropane (2.0
equiv.), KOH (0.2 equiv.) in MeOH, 0 ꢂC–rt, 3.5 h. c) Ac2O
(2.2 equiv.), DMAP (0.2 equiv.) in THF, 0 ꢂC–rt, 1 h. 7, 38% from
5. d) CNCH2CO2-t-Bu (1.0 equiv.), DBU (2.2 equiv.) in THF,
0 ꢂC–rt, overnight, 8, 67%. e) NIS (1.2 equiv.) in acetone, rt,
1 h. f) Pb(OAc)4 (1.5 equiv.) in toluene, rt, 2 d. 9, 90% from 8.
g) TsNa (2.1equiv.) in THF, reflux, 1.5 h. h) Boc2O (1.5 equiv.),
DMAP (0.2 equiv.) in MeCN, ꢁ40 ꢂC–rt, 1 h. i) In 0.5 M meth-
anolic HCl (prepared by diluting 12 M HCl with MeOH), rt, over-
night, 10, 92% from 9. j) I2 (1.2 equiv.), Ph3P (1.2 equiv.), imi-
dazole (2.5 equiv.) in MeCN, rt, 1 h. k) NaNO2 (2.0 equiv.), phloro-
glucinol dihydrate (1.1 equiv.) in DMF, rt, 7 h. l) OHCCH2-
CH2CO2-Allyl (2.0 equiv.), KOH (0.3 equiv.) in THF, 0 ꢂC–rt,
overnight, 11, 24% from 10. m) Ac2O (1.1 equiv.), DMAP
(0.2 equiv.) in THF, 0 ꢂC, 2 h. n) CNCH2CO2-t-Bu (4.0 equiv.),
DBU (5.0 equiv.) in MeCN, 0 ꢂC–rt, 4 h. 12, 82% from 11.
Universitat Berlin for giving us helpful information.
¨
References and Notes
1
2
3
T. Lamparter, N. Michael, O. Caspani, T. Miyata, K. Shirai, and K.
Inomata, J. Biol. Chem., 278, 33786 (2003).
M. A. Mroginski, D. H. Murgida, D. von Stetten, C. Kneip, F. Mark,
and P. Hildebrandt, J. Am. Chem. Soc., 126, 16734 (2004).
a) K. Kohori, M. Hashimoto, H. Kinoshita, and K. Inomata, Bull.
Chem. Soc. Jpn., 67, 3088 (1994). b) T. Kakiuchi, H. Kato, K. P.
Jayasundera, T. Higashi, K. Watabe, D. Sawamoto, H. Kinoshita,
and K. Inomata, Chem. Lett., 1998, 1001. c) K. P. Jayasundera, H.
Kinoshita, and K. Inomata, Chem. Lett., 1998, 1227. d) T. Kakiuchi,
H. Kinoshita, and K. Inomata, Synlett, 1999, 901. e) A. Ohta, D.
Sawamoto, K. P. Jayasundera, H. Kinoshita, and K. Inomata, Chem.
Lett., 2000, 492. f) D. Sawamoto, H. Nakamura, H. Kinoshita, S.
Fujinami, and K. Inomata, Chem. Lett., 2000, 1398. See also the refer-
ences cited therein.
4
5
H. Hanzawa, K. Inomata, H. Kinoshita, T. Kakiuchi, K. P.
Jayasundera, D. Sawamoto, A. Ohta, K. Uchida, K. Wada, and M.
Furuya, Proc. Natl. Acad. Sci. U.S.A., 98, 3612 (2001); A related paper
was reported: U. Robben, I. Lindner, W. Gartner, and K. Schaffner,
¨
Angew. Chem., Int. Ed., 40, 1048 (2001).
a) H. Hanzawa, T. Shinomura, K. Inomata, T. Kakiuchi, H. Kinoshita,
K. Wada, and M. Furuya, Proc. Natl. Acad. Sci. U.S.A., 99, 4725
(2002). b) K. Inomata, Chemistry Today, No. 398, 56 (2004).
M. A. S. Hammam, Y. Murata, H. Kinoshita, and K. Inomata, Chem.
Lett., 33, 1258 (2004).
O
O
Me
Me
NBoc
CO2tBu
NH
CO2H
Ts
Ts
CHO
CHO
b
a
12
NH
NH
CO2tBu
CO2H
6
7
8
AllylO2C
O
AllylO2C
O
13
D. H. R. Barton, J. Kervogoret, and S. Z. Zard, Tetrahedron, 46, 7587
(1990).
NH
Me
NH
Me
D
1H NMR spectrum of compound 4: (CDCl3, 400 MHz) ꢁ 1.13 (t J ¼
7:6 Hz, 3H), 1.96 (p 6.4, 2H), 2.36–2.42 (m, 4H), 2.51 (t 6.6, 2H),
2.64 (t 7.7, 2H), 3.08 (t 7.7, 2H), 4.57 (d 5.9, 2H), 5.23 (dd 10.5,
1.2, 1H), 5.28 (dd 17.3, 1.5, 1H), 5.88 (ddt 17.2, 10.5, 5.9, 1H), 6.19
(s, 1H), 8.31 (brs, 1H), 9.63 (s, 1H), 9.98 (brs, 1H).
c
d
NH
NH
C
CO2H
CHO
CO2Allyl
14
CO2Allyl
9
1H NMR spectrum of compound 1: (C5D5N, 400 MHz) ꢁ 1.17 (t
J ¼ 7:5 Hz, 3H), 1.94 (m, 2H), 2.06 (s, 3H), 2.12 (s, 3H), 2.32 (t 6.1,
2H), 2.44 (q 7.5, 2H), 2.53 (t 6.1, 2H), 2.88 (t 7.3, 4H), 3.20 (t 7.1,
2H), 3.21 (t 7.3, 2H), 5.60 (d 11.7, 1H), 6.74 (d 17.8, 1H), 6.27
(s, 1H), 6.72 (dd 11.4, 17.8, 1H), 6.72 (s, 1H), 7.59 (s, 1H), 8.42 (s,
1–2H), 11.76 (s, 1H). CO2H protons were not observed clearly. UV–
vis (MeOH) ꢂmax 381 (" ¼ 40;533), 630 (" ¼ 29;260) nm; HRMS
(FAB) [M þ 1]þ, Found: m=z 597.2741. Calcd for C34H37N4O6:
597.2713.
4
e
f
2
1
Scheme 2. a) POCl3 (2.0 equiv.) in DMF, 65 ꢂC, 2 h, then aq
10% NaOAc. 13, 68%. b) 99% HCO2H, rt, overnight. c) n-Bu3P
(2.5 equiv.), DBU (1.5 equiv.) in THF/DMF, ꢁ75 ꢂC–rt, over-
night. 14, 74%. d) TFA/(MeO)3CH (2/1, v/v), 0 ꢂC–rt, 1 h, then
H2O. 4, 40%. e) 3, H2SO4 (2.0 equiv.) in MeOH, rt, 1 h. 2, 71%. f)
[Pd(PPh3)4] (0.2 equiv.), TsNa (2.1 equiv.) in THF/MeOH (1/1,
v/v), rt, 10 min. 1, 70%.
10 Personal communication to K. I. from T. Lamparter and S. Noack,
Freie Universitat Berlin. The detailed investigation for the resulting
¨
holoprotein is in progress.
Published on the web (Advance View) May 14, 2005; DOI 10.1246/cl.2005.800